Novo Nordisk A/S (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 89   

Articles published

NVO 45.72 +0.38 (0.84%)
price chart
Sanofi And Novo Nordisk's Basal-Insulin Battle Continues
Sanofi SA (ADR) (SNY) and Novo Nordisk A/S (ADR) (NVO) are the two main players in the ongoing race for developing effective basal insulin therapies for the treatment of diabetes.
Related articles »  
Novo Nordisk A/S Receives "Neutral" Rating from Zacks (NVO)
Novo Nordisk A/S (ADR) logo Zacks reissued their neutral rating on shares of Novo Nordisk A/S (NYSE:NVO) in a research report sent to investors on Monday morning.
Traders Alert - Altria Group Inc (NYSE:MO), Novo Nordisk A/S (ADR) (NYSE ...  Techsonian (press release)
Related articles »  
Novo Nordisk A/S Given Neutral Rating at Zacks (NVO)
Novo Nordisk A/S (ADR) logo Zacks restated their neutral rating on shares of Novo Nordisk A/S (NYSE:NVO) in a research note issued to investors on Monday.
Related articles »  
Investor's Alert �Novo Nordisk A/S (ADR) (NVO), Entergy Corporation (NYSE ...
Las Vegas, NV - October 03, 2014� (TechSonian) - Novo Nordisk A/S (ADR) (NYSE:NVO) posted that it is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products.
Related articles »  
Novo Nordisk A/S Stock Rating Reaffirmed by Zacks (NVO)
Novo Nordisk A/S (ADR) logo Novo Nordisk A/S (NYSE:NVO)'s stock had its �neutral� rating reissued by Zacks in a research note issued on Monday.
Stocks in the News �Novo Nordisk A/S (ADR) (NYSE:NVO), The Dow Chemical ...
Manhattan, NY- October 10, 2014 - (Techsonian) - Novo Nordisk A/S (ADR) (NYSE:NVO) posted that it is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products.
Related articles »  
Higher gross margins are more profitable: Entergy Corporation (ETR), Novo ...
Novo Nordisk A/S (ADR) (NYSE:NVO) has 9.00% institutional ownership while its EPS ratio was 1.68. The company has 2.13 billion shares outstanding while market capitalization of the company was $101.97 billion.
4 High-Profit Margin Stocks: JPMorgan Chase & Co. (NYSE:JPM), Unilever plc ...
Novo Nordisk A/S (ADR) (NYSE:NVO) has 7% institutional ownership while its EPS ratio was 1.68. The company has 2.51B shares outstanding while market capitalization of the company was $ 94.41B.
Traders Recap: Novo Nordisk A/S (NYSE:NVO), Ecolab Inc. (NYSE:ECL ...
Novo Nordisk A/S (ADR) (NYSE:NVO) decreased -1.07% and closed at $47.08 on a traded 1.07 million shares of average trading volume.
EBOLA Endemic Should Be An Eye-Opener For The FDA
Another example is Tresiba, the long-acting insulin drug manufactured by Novo Nordisk A/S (ADR) (NYSE:NVO) to treat Type-1 diabetes.
Related articles »